David Mitchell, founder of Patients for Affordable Drugs, looks at the US pharmaceutical industry from the patients’ perspective.
This is both a hopeful and terrifying time to be a patient in the USA
David Mitchell – Founder, Patients for Affordable Drugs, USA
29.04.2019
David Mitchell, founder of Patients for Affordable Drugs, looks at the US pharmaceutical industry from the patients’ perspective.
Related Interviews
Melanie Croce-Galis – Director, US Patient Engagement, Oncology, Novartis
Melanie Croce-Galis, RN, MPH explains the specificities of her work as patient engagement lead for Novartis Oncology in the US market, where significant disparities in patient access to information and…
Claire Saxton – Vice President, Patient Experience & Lauren Kriegel…
Claire Saxton and Lauren Kriegel of Cancer Support Community, the largest professionally led non-profit network of cancer support worldwide, discuss how cancer patient and caregiver perspectives need to be better…
Paediatric Oncology / Dr Navin Pinto on CAR-T's Potential
Paediatric oncologist Navin Pinto, MD outlines the current use and potential of CAR-T therapies in his field, including the manufacturing challenges that still need to be addressed. Dr Pinto also…
CAR-T / Patient Engagement Roundtable: A Varied Global Picture
As complex cutting-edge therapies come online, industry sponsors are increasingly looking to engage with patients, caregivers, and advocacy groups earlier and more broadly in the drug development process to better…
Investment / J.P. Morgan Healthcare Conference 2022: Glass Half Full
David H. Crean summarizes the recent 40th annual J.P. Morgan Healthcare Conference 2022 that was held in a virtual format. Crean underlines the importance of the Conference for establishing the tone…
Top 10 Global Pharma Markets Ranking
Based on IQVIA’s pharma market rankings for 2020, we give a rundown of the global top 10, key companies, important trends, and where you can go to learn more. …
Latest Report
